Heterocyclic n-aryl carboxamides as cytokine inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/12 (2006.01) A61K 31/404 (2006.01) A61P 29/00 (2006.01) C07D 401/12 (2006.01)

Patent

CA 2518774

Disclosed are compounds of formula (I) where Ar1, X, Y, Q, W, R3, R4, R5, R6 and Ry are defined herein. The compounds of the invention inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

L'invention concerne des composés de formule générale (I) dans laquelle Ar¿1?, X, Y, Q, W, R?3¿, R?4¿, R?5¿, R?6¿ et R?y¿ ont la signification indiquée dans la description. Ces composés inhibent la production de cytokines impliquées dans des processus inflammatoires et s'avèrent ainsi utiles pour le traitement de maladies et d'états pathologiques impliquant une inflammation de type maladie inflammatoire chronique. L'invention concerne également des procédés de préparation desdits composés et des compositions pharmaceutiques comprenant ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic n-aryl carboxamides as cytokine inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic n-aryl carboxamides as cytokine inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic n-aryl carboxamides as cytokine inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1970058

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.